MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 11.00
-0.35 (-3.08%)
Jul 14, 2026, 1:21 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 711.93 million as of July 14, 2026. Its market cap has decreased by -33.13% in one year.
Market Cap
711.93M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
11.00
Market Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 711.93M, a decrease of -66.31%. That is a compound annual growth rate of -20.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 711.93M | -11.65% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 997.31M |
| GeneReach Biotechnology | 979.88M |
| TCI GENE | 978.96M |
| Meribank Biotech | 964.56M |
| Taiwan Advance Bio-Pharmaceutical | 891.90M |
| NatureWise Biotech & Medicals | 834.71M |
| BioLASCO Taiwan | 752.99M |
| SynCore Biotechnology Co.,Ltd | 720.87M |